Related Experiment Video
Updated: Jan 15, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Management of Arrhythmic Mitral Valve Prolapse: Potential Impact and Current Evidence
Serghei Covantsev1, Andia Taghdiri2, Anna Bumbu1
1Department of Clinical Research and Development, Botkin Hospital, 125284 Moscow, Russia.
Abstract:
Mitral valve prolapse (MVP), also known as floppy mitral valve syndrome, systolic click-murmur syndrome, and billowing mitral leaflets, is a developmental anomaly caused when one or two abnormal valve leaflets are displaced into the left atrium below the mitral valve annulus during systole. MVP is observed in 2-3% of patients in the general population and is the leading cause of mitral regurgitation (MR) in developed countries. Overall, MVP is considered a benign developmental anomaly; however, evidence suggests that MVP is associated with sudden cardiac death. Thus, there have been ongoing discussions about the optimal management of this patient group, which includes both pharmacological treatment and surgical interventions. This review aimed to provide an overview of the benign and arrhythmic MVP (AMVP), its diagnostic options, and management possibilities.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse III: Nursing Management
Mitral Stenosis IV: Nursing Management

